Vincent Palmieri is Director at XRpro Sciences, Inc. (NONE). They have made 1 open-market trade across 1 company since 2017, most recently 2017-12-29.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $8K since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PrivateUnlisted | 64,736 | — |
Shares reported on the most recent Form 4, priced at the 2018-01-02 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PrivateIcagen, Inc. | BUY | 2017-12-29 | 2018-01-02 | $0.37 | $8K | N/A | N/A | N/A |